DaVita Healthcare Partners | DVA - Sales Revenues

Stock Price
142.06
Daily Change
7.33 5.44%
Monthly
24.68%
Yearly
-19.68%
Q1 Forecast
105.97

DaVita Healthcare Partners reported $3.62B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Acadia Healthcare USD 851.6M 17.6M Sep/2025
Addus HomeCare USD 362.3M 12.9M Sep/2025
Brookdale Senior Living USD 813.16M 34.92M Sep/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Centene USD 49.69B 950M Sep/2025
Chemed USD 624.9M 6.1M Sep/2025
Cigna USD 72.47B 2.77B Dec/2025
Corvel USD 240M 5.29M Sep/2025
CVS Health USD 102.9B 3.99B Sep/2025
DaVita Healthcare Partners USD 3.62B 200M Dec/2025
Elevance Health USD 49.3B 790M Dec/2025
Encompass Health USD 1.48B 20M Sep/2025
Ensign USD 1.36B 60M Dec/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 4.89B 100M Sep/2025
HCA USD 19.51B 350M Dec/2025
Humana USD 32.65B 260M Sep/2025
Laboratory Of America USD 3.56B 30M Sep/2025
McKesson USD 106.16B 3.01B Dec/2025
Molina Healthcare USD 11.48B 50M Sep/2025
Option Care Health USD 1.44B 20M Sep/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
RadNet USD 522.87M 24.64M Sep/2025
Select Medical USD 1.36B 80M Sep/2025
Tenet Healthcare USD 5.29B 20M Sep/2025
UnitedHealth USD 113.2B 0 Dec/2025
Universal Health Services USD 4.5B 220M Sep/2025